mozavaptan has been researched along with relcovaptan in 8 studies
Studies (mozavaptan) | Trials (mozavaptan) | Recent Studies (post-2010) (mozavaptan) | Studies (relcovaptan) | Trials (relcovaptan) | Recent Studies (post-2010) (relcovaptan) |
---|---|---|---|---|---|
165 | 8 | 24 | 120 | 9 | 40 |
Protein | Taxonomy | mozavaptan (IC50) | relcovaptan (IC50) |
---|---|---|---|
Vasopressin V1a receptor | Homo sapiens (human) | 0.013 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berti-Mattera, LN; Dulin, N; Mattera, R; Preston, JA; Thibonnier, M; Wilkins, PL | 1 |
Ishii, N; Kusayama, T; Saito, M; Sugimoto, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T | 1 |
Double-Cazanave, E; Garcia, C; Guillon, G; Maffrand, JP; Pascal, M; Raufaste, D; Serradeil-Le Gal, C | 1 |
Bax, WA; Bos, E; Nisato, D; Saxena, PR; Stam, WB; Van der Graaf, PH | 1 |
Calò, G; Regoli, D; Rizzi, A; Traina, L | 1 |
Ishikawa, S; Saito, T | 1 |
Lankhuizen, IM; Saxena, PR; Schoemaker, RG; van Veghel, R | 2 |
1 review(s) available for mozavaptan and relcovaptan
Article | Year |
---|---|
[Disorders of body water regulation and the therapy--vasopressin antagonists].
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Indoles; Liver Cirrhosis, Experimental; Pyrrolidines | 1997 |
7 other study(ies) available for mozavaptan and relcovaptan
Article | Year |
---|---|
The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways.
Topics: Animals; Arachidonic Acid; Base Sequence; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; CHO Cells; Cricetinae; Cyclic AMP; DNA; Dose-Response Relationship, Drug; Female; Humans; Ligands; Pertussis Toxin; Phenotype; Phosphorylation; Pituitary Gland; Protein Binding; Protein Kinase C; Receptors, Vasopressin; Signal Transduction; Thymidine; Tritium; Type C Phospholipases; Virulence Factors, Bordetella | 1997 |
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
Topics: Animals; Benzazepines; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Cyclic AMP; Humans; Indoles; Morpholines; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Spiro Compounds; Transfection; Tritium | 1998 |
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Binding, Competitive; Cattle; CHO Cells; Cricetinae; Dogs; Haplorhini; Homeostasis; Humans; Kidney; Kinetics; Morpholines; Rabbits; Radioligand Assay; Rats; Spiro Compounds; Swine; Tritium; Vasopressins; Water-Electrolyte Balance | 2000 |
[Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists.
Topics: Adolescent; Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Child; Coronary Vessels; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Indoles; Male; Middle Aged; Muscle, Smooth, Vascular; Piperidines; Potassium; Pyrrolidines; Quinolones; Vasoconstrictor Agents | 1995 |
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arteries; Benzazepines; Humans; In Vitro Techniques; Indoles; Middle Aged; Muscle, Smooth, Vascular; Oxytocin; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Stomach; Vasoconstrictor Agents | 1997 |
[Arg8]-vasopressin-induced responses on coronary and mesenteric arteries of rats with myocardial infarction: the effects of V1a- and V2-receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Coronary Circulation; Coronary Vessels; Indoles; Ligation; Male; Mesenteric Arteries; Myocardial Infarction; Pyrrolidines; Rats; Rats, Wistar; Receptors, Vasopressin; Vasoconstrictor Agents | 2000 |
Vascular and renal effects of vasopressin and its antagonists in conscious rats with chronic myocardial infarction; evidence for receptor shift.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Chronic Disease; Consciousness; Coronary Vessels; Dose-Response Relationship, Drug; Indoles; Kidney; Ligation; Male; Myocardial Infarction; Pyrrolidines; Rats; Rats, Wistar; Receptors, Vasopressin; Urination; Urodynamics; Vasopressins | 2001 |